BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23176702)

  • 1. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.
    Turksma AW; Bontkes HJ; van den Heuvel H; de Gruijl TD; von Blomberg BM; Braakhuis BJ; Leemans CR; Bloemena E; Meijer CJ; Hooijberg E
    Oral Dis; 2013 Sep; 19(6):577-84. PubMed ID: 23176702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Adv Otorhinolaryngol; 2005; 62():161-72. PubMed ID: 15608426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
    Tsukishiro T; Donnenberg AD; Whiteside TL
    Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
    Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
    Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
    J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.
    Kuss I; Schaefer C; Godfrey TE; Ferris RL; Harris JM; Gooding W; Whiteside TL
    Clin Immunol; 2005 Jul; 116(1):27-36. PubMed ID: 15925829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a simplified dual-platform flow cytometric method for measurement of lymphocyte subsets and T-cell maturation phenotypes in the population of Nouna, Burkina Faso.
    Böhler T; von Au M; Klose N; Müller K; Coulibaly B; Nauwelaers F; Spengler HP; Kynast-Wolf G; Kräusslich HG
    Clin Vaccine Immunol; 2007 Jun; 14(6):775-81. PubMed ID: 17442847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity.
    Green VL; Michno A; Stafford ND; Greenman J
    Cancer Immunol Immunother; 2013 May; 62(5):863-73. PubMed ID: 23359088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
    Oguejiofor K; Hall J; Slater C; Betts G; Hall G; Slevin N; Dovedi S; Stern PL; West CM
    Br J Cancer; 2015 Sep; 113(6):886-93. PubMed ID: 26313665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
    Doxtader EE; Katzenstein AL
    Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma.
    Mineta H; Ogino T; Amano HM; Ohkawa Y; Araki K; Takebayashi S; Miura K
    Anticancer Res; 1998; 18(6B):4765-8. PubMed ID: 9891554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
    Ribeiro KB; Levi JE; Pawlita M; Koifman S; Matos E; Eluf-Neto J; Wunsch-Filho V; Curado MP; Shangina O; Zaridze D; Szeszenia-Dabrowska N; Lissowska J; Daudt A; Menezes A; Bencko V; Mates D; Fernandez L; Fabianova E; Gheit T; Tommasino M; Boffetta P; Brennan P; Waterboer T
    Int J Epidemiol; 2011 Apr; 40(2):489-502. PubMed ID: 21224273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.
    Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM
    Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.